Multiple Myeloma in the Era of Novel Agents and Stem Cell Therapies
The recent availability of several lines of novel therapeutic agents such as immunomodulatory agents, proteasome inhibitors, and monoclonal antibodies; the widespread utilization of hematopoietic stem cell transplantation; the use of advanced diagnostic techniques that allow risk stratification and...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/85536 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Multiple Myeloma in the Era of Novel Agents and Stem Cell Therapies
- Outpatient Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
- An Update on Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
- Introductory Chapter: Update on Multiple Myeloma
- Cancer Stem Cells in Multiple Myeloma
- Stem Cell Mobılızatıon in Multıple Myeloma
- The Current Role of Stem Cell Transplantation in Multiple Myeloma